Drug releasing stents

Drug eluting stents have become a mainstream in the treatment of coronary heart disease. Implementation of this technology into medical practice has resulted in a dramatic reduction in restenosis rates and late loss, which in turn is reflected in a significant reduction in MACE events due predominan...

Full description

Saved in:
Bibliographic Details
Published in:Archivos de cardiología de México 2003-04, Vol.73 Suppl 1, p.S17-S20
Main Author: Ban Hayashi, Ernesto
Format: Article
Language:Spanish
Subjects:
Antibiotics, Antineoplastic - administration & dosage
Antineoplastic Agents, Phytogenic - administration & dosage
Clinical Trials as Topic
Coronary Disease - drug therapy
Drug Delivery Systems
Humans
Muscle, Smooth, Vascular - drug effects
Paclitaxel - administration & dosage
Sirolimus - administration & dosage
Stents
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Drug eluting stents have become a mainstream in the treatment of coronary heart disease. Implementation of this technology into medical practice has resulted in a dramatic reduction in restenosis rates and late loss, which in turn is reflected in a significant reduction in MACE events due predominantly to a reduction in the need of a new re-intervention in the treated vessel. Historical comparisons between surgical results and the recently published studies with drug eluting stents shows that survival free of major events and the need of new revascularization are about the same in both groups of patients.
ISSN:1405-9940